IF analyses for Hmox1 and Ftl1 revealed that Roxadustat treatment promoted the expression of Hmox1 and caused the degradation of Ftl1 compared to the melanoma group (Fig. 11f). This evidence concerns the gene HMOX1 and melanoma.